Occupational exposure in patients with the antisynthetase syndrome

被引:19
|
作者
Labirua-Iturburu, Ane [1 ]
Selva-O'Callaghan, Albert [1 ]
Zock, Jan-Paul [2 ,3 ,4 ]
Orriols, Ramon [5 ,7 ]
Martinez-Gomez, Xavier [6 ]
Vilardell-Tarres, Miquel [1 ]
机构
[1] Univ Autonoma Barcelona, Vall dHebron Gen Hosp, Dept Internal Med, C Siracusa 12 Bis A, Barcelona 08012, Spain
[2] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain
[3] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain
[4] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain
[5] Vall dHebron Gen Hosp, Serv Pneumol, Barcelona, Spain
[6] Vall dHebron Gen Hosp, Dept Prevent Med & Epidemiol, Barcelona, Spain
[7] CIBER Enfermedades Resp CIBERES, Palma De Mallorca, Spain
关键词
Antisynthetase antibodies; Antisynthetase syndrome; Interstitial lung disease; Occupational exposure; IDIOPATHIC INFLAMMATORY MYOPATHIES; INTERSTITIAL LUNG-DISEASE; CRYPTOGENIC FIBROSING ALVEOLITIS; ANTI-JO-1; ANTIBODIES; RNA-SYNTHETASE; DUST EXPOSURE; POLYMYOSITIS; MYOSITIS; PROGRESS; RISK;
D O I
10.1007/s10067-013-2467-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interstitial lung disease (ILD) is common in patients with myositis and is related with the presence of antisynthetase autoantibodies (aSA). Together with other manifestations, the resulting condition is known as the antisynthetase syndrome (ASS). Contact with certain environmental and occupational agents is also associated with the development of ILD. The objective of this study was to analyze occupational exposure and associated clinical manifestations in a cohort of patients with ASS. aSA had been identified by line immunoassay and confirmed by immunoprecipitation. Serial pulmonary function tests had been carried out to assess lung function. Thirty-two ASS patients and a control group of 32 myositis patients without aSA underwent a specific questionnaire interview to evaluate their cumulative exposure to biological dust, mineral dust, and gases/fumes up to disease onset. Comparisons were done with the Fisher exact test and Mann-Whitney test. Out from 32 ASS patients (median age, 42.7 yeras; IQR 32.2-52.5), twenty-six patients had anti-Jo-1, three anti-PL-12, and three anti-PL-7. Nine had polymyositis, 15 dermatomyositis, one amyopathic dermatomyositis, and seven pure ILD without myositis. Sixteen ASS patients (50 %) and seven (22 %) myositis patients without aSA had ever been highly exposed to dust, gases, or fumes (p < 0.05). A more than 10 % improvement in forced vital capacity occurred in 61 % of highly exposed patients and 23 % of those with low/no exposure (p = 0.06) over the observation period. In conclusion, a high percentage of patients with ASS had been exposed to dusts, gases, or fumes.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [21] Clinical manifestations and treatment of antisynthetase syndrome
    Marco, Joanna L.
    Collins, Bridget F.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2020, 34 (04):
  • [22] Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
    Cavagna, Lorenzo
    Trallero-Araguas, Ernesto
    Meloni, Federica
    Cavazzana, Ilaria
    Rojas-Serrano, Jorge
    Feist, Eugen
    Zanframundo, Giovanni
    Morandi, Valentina
    Meyer, Alain
    Pereira da Silva, Jose Antonio
    Matos Costa, Carlo Jorge
    Molberg, Oyvind
    Andersson, Helena
    Codullo, Veronica
    Mosca, Marta
    Barsotti, Simone
    Neri, Rossella
    Scire, Carlo
    Govoni, Marcello
    Furini, Federica
    Javier Lopez-Longo, Francisco
    Martinez-Barrio, Julia
    Schneider, Udo
    Lorenz, Hanns-Martin
    Doria, Andrea
    Ghirardello, Anna
    Ortego-Centeno, Norberto
    Confalonieri, Marco
    Tomietto, Paola
    Pipitone, Nicolo
    Rodriguez Cambron, Ana Belen
    Blazquez Canamero, Maria Angeles
    Voll, Reinhard Edmund
    Wendel, Sarah
    Scarpato, Salvatore
    Maurier, Francois
    Limonta, Massimiliano
    Colombelli, Paolo
    Giannini, Margherita
    Geny, Bernard
    Arrigoni, Eugenio
    Bravi, Elena
    Migliorini, Paola
    Mathieu, Alessandro
    Piga, Matteo
    Drott, Ulrich
    Delbrueck, Christiane
    Bauhammer, Jutta
    Cagnotto, Giovanni
    Vancheri, Carlo
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [23] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Wiley, K. D.
    Danoff, S. K.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 243 - 257
  • [24] Review of Pulmonary Manifestations in Antisynthetase Syndrome
    Ghanbar, Mohammad I.
    Danoff, Sonye K.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 365 - 385
  • [25] Efficacy of rituximab in refractory antisynthetase syndrome
    Limaye, V.
    Hissaria, P.
    Liew, C. -L.
    Koszyka, B.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (03) : E4 - E7
  • [26] Early symptoms of dermatomyositis and antisynthetase syndrome
    Maurer, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (10): : 970 - 976
  • [27] Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome
    Hervier, Baptiste
    Benveniste, Olivier
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (08)
  • [28] Antisynthetase syndrome: A distinct disease spectrum
    Huang, Kun
    Aggarwal, Rohit
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (03) : 178 - 191
  • [29] A multidisciplinary approach to the diagnosis of antisynthetase syndrome
    Wells, Matthew
    Alawi, Sughra
    Thin, Kyaing Yi Mon
    Gunawardena, Harsha
    Brown, Adrian R.
    Edey, Anthony
    Pauling, John D.
    Barratt, Shaney L.
    Adamali, Huzaifa I.
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Early symptoms of dermatomyositis and antisynthetase syndrome
    Maurer, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (10): : 970 - 976